Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects
Clinical trial NCT01445795 · COMPLETED
Trial details
- NCT number
- NCT01445795
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.